JAMES LEE to Adult
This is a "connection" page, showing publications JAMES LEE has written about Adult.
Connection Strength
0.138
-
Effect of CYP2C9 *11/*11 genotype on initial and long-term warfarin dose requirement and therapeutic response. Pharmacogenomics. 2020 12; 21(18):1271-1277.
Score: 0.038
-
Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement. Pharmacogenomics. 2017 Jul; 18(11):1051-1057.
Score: 0.030
-
Clinical and Financial Outcomes Evaluation of Multimodal Pharmacist Warfarin Management of a Statewide Urban and Rural Population. J Pharm Pract. 2018 Apr; 31(2):150-156.
Score: 0.030
-
Results of the ACCOuNT Trial: A Multi-Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients. Clin Pharmacol Ther. 2026 01; 119(1):109-119.
Score: 0.013
-
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. Ann Intern Med. 2023 04; 176(4):515-523.
Score: 0.011
-
Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus. PLoS One. 2021; 16(6):e0252549.
Score: 0.010
-
Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert system. BMC Med Genomics. 2014; 7 Suppl 1:S13.
Score: 0.006